TP53BP1 and cancer: It is also worth mentioning that the inactivation of 53BP1 was shown to potentiate homologous recombination and increase DNA damage tolerance of cancer-prone BRCA1 -/- cells [32], [76], [77], [78], with severe implications for therapeutic treatments.